EYPT logo

EyePoint Pharmaceuticals (EYPT)

Profile

Full Name

EyePoint Pharmaceuticals, Inc.

Ticker Symbol

EYPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 27, 2005

Indexes

Not included

Website

http://eyepointpharma.com

Employees

165

Key Details

Price

$5.71(+6.13%)

Market cap

$392.44M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$43.27M(-5.97% YoY)

Annual EPS

-$2.32(-27.47% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.71
EYPT price is $5.71

30-Day Relative Volume

1.04
EYPT 30-day relative volume is 1.04

Price Performance

Price Most recent change

+6.13%
EYPT price was up +6.13% on Apr 14, 2025

Price YTD change

-23.36%
EYPT price is down -23.36% since January 1st

Price 1-year change

-74.57%
EYPT price is down -74.57% year-on-year

Price 3-year change

-55%
EYPT price is down -55% over the past 3 years

Price Range

Price All-time high

$485.60
EYPT price is currently -98.82% below its historical high of $485.60

Price 3-year low

$2.19
EYPT price is currently +160.73% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$392.44M
EYPT market capitalization is $392.44 million

Market cap 3-year change

-9.17%
EYPT market capitalization is down -9.17% over the past 3 years

Market cap All-time high

$1.46B
EYPT market capitalization is currently -73.09% below its historical high of $1.46 billion

Market cap sector rank

65.82%
EYPT market capitalization is higher than 65.82% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+37.77%
EYPT shares outstanding is up +37.77% year-on-year

Shares Outstanding 3-Year Change

+101.86%
EYPT shares outstanding is up +101.86% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.31
EYPT beta is 1.31

200-day SMA

$8.22
EYPT price is currently -30.55% below its 200-day simple moving average

50-day SMA

$6.14
EYPT price is currently -7.02% below its 50-day simple moving average

RSI

51.13
EYPT 14-day relative strength index is 51.13

Volume

1.04
EYPT 30-day relative volume is 1.04

ATR

$0.58
EYPT average true range is $0.58

10-day Historical Volatility

132.07%
EYPT 10-day historical volatility is 132.07%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$43.27M
EYPT annual revenue is $43.27 million

Revenue Analysts estimate

$29.03M
EYPT annual revenue is currently +49.04% higher than the consensus analysts' forecast

Revenue 1-year change

-5.97%
EYPT annual revenue is down -5.97% year-on-year

Revenue Sector rank

45.24%
EYPT annual revenue is higher than 45.24% of companies in Healthcare sector

EPS

EPS

-$2.32
EYPT annual earnings per share is -$2.32

EPS Analysts estimate

-$2.05
EYPT annual earnings per share is currently +13.12% higher than the consensus analysts' forecast

EPS 1-year change

-27.47%
EYPT annual earnings per share is down -27.47% year-on-year

EPS Sector rank

35.84%
EYPT annual earnings per share is higher than 35.84% of companies in Healthcare sector

Profit

Gross profit

$39.56M
EYPT annual gross profit is $39.56 million

Gross margin

91.42%
EYPT annual gross profit margin is 91.42%

Operating profit

-$145.85M
EYPT annual operating income is -$145.85 million

Operating margin

-337.06%
EYPT annual operating profit margin is -337.06%

Net income

-$130.87M
EYPT annual net profit is -$130.87 million

Net margin

-302.43%
EYPT annual net profit margin is -302.43%

Expenses

Total expenses

$189.13M
EYPT annual total expenses is $189.13 million

Operating expenses

$185.41M
EYPT annual total operating expenses is $185.41 million

Cost of goods sold

$3.71M
EYPT annual cost of goods sold is $3.71 million

Selling, general & administrative expenses

$52.49M
EYPT annual SGA is $52.49 million

Depreciation and amortization

$1.54M
EYPT annual depreciation & amortization is $1.54 million

Interest expense

$14.00K
EYPT annual interest expense is $14.00 thousand

Income tax

$90.00K
EYPT annual income tax is $90.00 thousand

EBIT & EBITDA

EBIT

-$130.77M
EYPT annual earnings before interest & taxes is -$130.77 million

EBITDA

-$129.23M
EYPT annual EBITDA is -$129.23 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$418.46M
EYPT annual total assets is $418.46 million

Non current assets

$35.16M
EYPT annual long term assets is $35.16 million

Current assets

$383.31M
EYPT annual total current assets is $383.31 million

Cash and cash equivalents

$99.70M
EYPT annual cash & cash equivalents is $99.70 million

Accounts receivable

$607.00K
EYPT annual accounts receivable is $607.00 thousand

Inventory

$2.31M
EYPT annual inventory is $2.31 million

Liabilities

Total liabilities

$81.96M
EYPT annual total liabilities is $81.96 million

Long term liabilities

$32.92M
EYPT annual total long term liabilities is $32.92 million

Current liabilities

$49.05M
EYPT annual total current liabilities is $49.05 million

Accounts payable

$11.72M
EYPT annual accounts payable is $11.72 million

Debt

Total debt

$21.86M
EYPT annual total debt is $21.86 million

Total debt 1-year change

+345.54%
EYPT annual total debt is up +345.54% year-on-year

Long term debt

$21.86M
EYPT annual long term debt is $21.86 million

Short term debt

-
EYPT annual short term debt value is unknown

Equity & Capital

Shareholders equity

$336.50M
EYPT annual stockholders equity is $336.50 million

Book value

$336.50M
EYPT annual book value is $336.50 million

Retained earnings

-$873.02M
EYPT annual retained earnings is -$873.02 million

Working capital

$334.26M
EYPT annual working capital is $334.26 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$126.23M
EYPT annual cash flow from operations is -$126.23 million

Cash from operations 1-year change

-6832.05%
EYPT annual cash flow from operations is down -6832.05% year-on-year

Cash from investing

-$219.35M
EYPT annual cash flow from investing activities is -$219.35 million

Cash from investing 1-year change

-6517.04%
EYPT annual cash flow from investing activities is down -6517.04% year-on-year

Cash from financing

$164.02M
EYPT annual cash flow from financing activities is $164.02 million

Cash from financing 1-year change

-12.32%
EYPT annual cash flow from financing activities is down -12.32% year-on-year

CAPEX

CAPEX

$4.05M
EYPT annual capital expenditures is $4.05 million

CAPEX 1-year change

+16.34%
EYPT annual capital expenditures is up +16.34% year-on-year

Free Cash Flow

Free cash flow

-$130.28M
EYPT annual free cash flow is -$130.28 million

Free cash flow 1-year change

-8001.87%
EYPT annual free cash flow is down -8001.87% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

91.42%
EYPT annual gross profit margin is 91.42%

Operating margin

-337.06%
EYPT annual operating profit margin is -337.06%

Net margin

-302.43%
EYPT annual net profit margin is -302.43%

ROA & ROE

ROA

-33.83%
EYPT annual return on assets is -33.83%

ROE

-43.42%
EYPT annual return on equity is -43.42%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EYPT price to earnings ratio value is unknown

PE ratio Sector rank

-
EYPT price to earnings ratio is unknown

PB Ratio

PB ratio

1.17
EYPT price to book ratio is 1.17

PB ratio Sector rank

47.53%
EYPT price to book ratio is higher than 47.53% of companies in Healthcare sector

PS Ratio

PS ratio

9.07
EYPT price to sales ratio is 9.07

PS ratio Sector rank

77.82%
EYPT price to sales ratio is higher than 77.82% of companies in Healthcare sector

Enterprise value

Enterprise value

$314.60M
EYPT enterprise value is $314.60 million

Enterprise value Sector rank

63.75%
EYPT enterprise value is higher than 63.75% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.43
EYPT EV/EBITDA is -2.43

EV/EBITDA Sector rank

29.11%
EYPT EV/EBITDA is higher than 29.11% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.81
EYPT annual current ratio is 7.81

Quick ratio

7.77
EYPT annual quick ratio is 7.77

Leverage

Debt to equity

0.00
EYPT annual debt to equity ratio is 0.00

Interest coverage ratio

-9340.43
EYPT annual interest coverage ratio is -9340.43

Risk & Stability

Piotroski F-Score

3
EYPT piotroski f-score is 3

Altman Z-Score

-0.02
EYPT altman z-score is -0.02

Analyst ratings

Recent major analysts updates

Mar 6, 25 HC Wainwright & Co.
Buy
Mar 6, 25 Chardan Capital
Buy
Feb 6, 25 Chardan Capital
Buy
Jan 7, 25 Citigroup
Buy
Dec 5, 24 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 11, 24 Baird
Outperform
Nov 8, 24 Chardan Capital
Buy
Oct 29, 24 Chardan Capital
Buy
Oct 25, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

PACB logo
Pacific Biosciences of California (PACB)
Enhabit (EHAB)
ABSI logo
Absci (ABSI)
ANGO logo
AngioDynamics (ANGO)
DCTH logo
Delcath Systems (DCTH)
PRTC logo
PureTech Health (PRTC)
SENS logo
Senseonics Holdings (SENS)
INNV logo
InnovAge Holding (INNV)
ABVX logo
ABIVAX SA (ABVX)
  • What is the ticker symbol for EyePoint Pharmaceuticals?
  • Does EyePoint Pharmaceuticals pay dividends?
  • What sector is EyePoint Pharmaceuticals in?
  • What industry is EyePoint Pharmaceuticals in?
  • What country is EyePoint Pharmaceuticals based in?
  • When did EyePoint Pharmaceuticals go public?
  • Is EyePoint Pharmaceuticals in the S&P 500?
  • Is EyePoint Pharmaceuticals in the NASDAQ 100?
  • Is EyePoint Pharmaceuticals in the Dow Jones?
  • When was EyePoint Pharmaceuticals's last earnings report?
  • When does EyePoint Pharmaceuticals report earnings?
  • Should I buy EyePoint Pharmaceuticals stock now?

What is the ticker symbol for EyePoint Pharmaceuticals?

The ticker symbol for EyePoint Pharmaceuticals is NASDAQ:EYPT

Does EyePoint Pharmaceuticals pay dividends?

No, EyePoint Pharmaceuticals does not pay dividends

What sector is EyePoint Pharmaceuticals in?

EyePoint Pharmaceuticals is in the Healthcare sector

What industry is EyePoint Pharmaceuticals in?

EyePoint Pharmaceuticals is in the Biotechnology industry

What country is EyePoint Pharmaceuticals based in?

EyePoint Pharmaceuticals is headquartered in United States

When did EyePoint Pharmaceuticals go public?

EyePoint Pharmaceuticals's initial public offering (IPO) was on January 27, 2005

Is EyePoint Pharmaceuticals in the S&P 500?

No, EyePoint Pharmaceuticals is not included in the S&P 500 index

Is EyePoint Pharmaceuticals in the NASDAQ 100?

No, EyePoint Pharmaceuticals is not included in the NASDAQ 100 index

Is EyePoint Pharmaceuticals in the Dow Jones?

No, EyePoint Pharmaceuticals is not included in the Dow Jones index

When was EyePoint Pharmaceuticals's last earnings report?

EyePoint Pharmaceuticals's most recent earnings report was on Mar 5, 2025

When does EyePoint Pharmaceuticals report earnings?

The next expected earnings date for EyePoint Pharmaceuticals is May 8, 2025

Should I buy EyePoint Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page